FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079027 [Registered on: 20/01/2025] Trial Registered Prospectively
Last Modified On: 16/02/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cognitive Intervention]  
Study Design  Other 
Public Title of Study   Cognitive Interventions in First Episode Psychosis-RCT  
Scientific Title of Study   A Randomized Controlled Trial of cognitive interventions in Patients with First Episode Psychosis to improve cognitive outcomes. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Swapnajeet Sahoo 
Designation  Associate Professor 
Affiliation  Post Graduate Institute of Medical Education & Research, Chandigarh 
Address  Department of Psychiatry PGIMER, Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  8872727744  
Fax    
Email  swapnajit.same@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Swapnajeet Sahoo 
Designation  Associate Professor 
Affiliation  Post Graduate Institute of Medical Education & Research, Chandigarh 
Address  Department of Psychiatry PGIMER, Chandigarh


CHANDIGARH
160012
India 
Phone  8872727744  
Fax    
Email  swapnajit.same@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Swapnajeet Sahoo 
Designation  Associate Professor 
Affiliation  Post Graduate Institute of Medical Education & Research, Chandigarh 
Address  Department of Psychiatry PGIMER, Chandigarh


CHANDIGARH
160012
India 
Phone  8872727744  
Fax    
Email  swapnajit.same@gmail.com  
 
Source of Monetary or Material Support  
Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911Ansari Nagar, New Delhi - 110029, India  
 
Primary Sponsor  
Name  Indian Council of Medical Research  
Address  AIIMS Campus Temple, Ansari Nagar East, New Delhi, Delhi 110029 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Swapnajeet Sahoo  Postgraduate Institute of Medical Education and Research (PGIMER), sector 12. Chandigarh  Department of Psychiatry New OPD Room No. 217
Chandigarh
CHANDIGARH 
8872727744

swapnajit.same@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Postgraduate Institute of Medical Education and Research, Chandigarh- I nstitutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F20||Schizophrenia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Cognitive Intervention  Domains: Attention, Working Memory (WM), Cognitive Flexibility (CF), Response Inhibition (RI), Memory (M) Social Cognition (SC). 12 weeks of cognitive intervention with 2 therapist delivered sessions per week and 5 days of home work assignments or worksheets supervised by the caregiver. WEEK 1 and WEEK 2 will focus on ATTENTION with Target cancellation task for selective attention and Grain sorting task for information processing speed and focused attention. WEEK 3 and WEEK 4 will focus on WORKING MEMORY with Digit Forward-Letter Forward task, Digit Backward-Letter Backward task and Shopping list task. WEEK 5 will focus on COGNITIVE FLEXIBILITY with the Card Sorting Task. WEEK 6 will focus on RESPONSE INHIBITION with the Design colouring Task. WEEK 7 and WEEK 8 will focus on MEMORY with the Paired word association learning Task and Vocabulary Recall Task. WEEK 9 to WEEK 12 will focus on SOCIAL COGNITION with tasks of Defining emotions, Identifying emotions, Guessing the emotions, Identifying facial expressions, Emotional attention shaping and Basic Social skills training.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Diagnosed with schizophrenia as per DSM-5 criteria5, with duration of illness less than 5 years
Currently in clinical remission as defined by Andreasen et al 20056.
 
 
ExclusionCriteria 
Details  Patients who were not in clinical remission
Those with comorbid organic brain syndrome or intellectual disability
Those refuse to consent for the study
 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Equal to or more than for FOToM 0.98 SOToM 0.82 FPCI 0.91 SPI 0.89 SPI High Intensity 0.92 SPI Low Intensity 0.86 NSPI 0.93 NSPI High Intensity 0.94 NSPI Low Intensity 0.87 DF 10.04 DB 7.45 COWA Average New words 11.66 AVLT LTPR 93.45 Immediate Recall 13.33 Delayed Recall 13.41 Total Learning score 60 Interference 8.12 Hits 14.66 SPM IQ 122.12
Equal to or Less than for CTMT Part A 29.54 Part B 69 SCWT score 42.16 Misses 0.33 False Alarms 0.41
 
12 weeks post intervention 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in Level of functioning, disability and quality of life from baseline scores   12 weeks post intervention 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

Aim: To evaluate the efficacy of cognitive-based interventions in patients with first episode psychosis and to evaluate if it can improve the overall course and outcome of patients with FEP over the period of 6 months.

Objectives: To compare of the level of functioning, psychopathology, social cognitions, neurocognitions, quality of life, stigma, insight, and disability, in patients with FEP at the baseline. To develop cognitive rehabilitation intervention package. To evaluate improvement in cognitive deficits following cognitive interventions after a duration of 6 months vis-à-vis in the TAU arm.

Methods: This is a randomized control trial for the duration of 3 years. Those randomized to cognitive intervention arm will be assessed at baseline, at the end of the trial and after 6 months to evaluate the effect of cognitive interventions on the overall course and outcome. The sample is being obtained from the patient population attending outpatient or inpatient services of Department of Psychiatry of PGIMER, Chandigarh. The study sample will comprise 300 patients with FEP of which 150 will be randomized to each group (Intervention group and TAU group). Patients in both intervention and non-intervention group will be subjected to Treatment as usual which includes psycho-education, medications and periodic routine follow up. In the intervention group, additional cognitive remediation measures will be provided as per the cognitive deficits of the individual patient.

Outcome: The improvement of the level of functioning, psychopathology, social cognitions, neurocognitions, quality of life, stigma, insight, and disability in patients with FEP at the baseline. The development of cognitive rehabilitation intervention package. The evaluation of improvement in cognitive deficits following cognitive interventions after a duration of 6 months vis-à-vis in the TAU arm.

 
Close